Trials / Unknown
UnknownNCT05251298
"Parkinson AKTIV - Non-pharmacological Treatments in an Innovative Parkinson's Network"
"Parkinson AKTIV - Non-pharmacological Treatments in an Innovative Parkinson's Network"- Evaluates the Efficacy of an Online Platform That Allows Neurologists and Therapists to Exchange Therapy Recommendations Regarding Their Patients With Parkinson's Disease (PwP), Communicate Assessments and Plan Physical Therapy, Occupational Therapy as Well as Speech and Swallowing Therapy
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 370 (estimated)
- Sponsor
- University Hospital Muenster · Academic / Other
- Sex
- All
- Age
- 30 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the efficacy of an online platform that allows neurologists and therapists to exchange therapy recommendations, communicate assessments and plan physical therapy, occupational therapy as well as speech and swallowing therapy for their patients.
Detailed description
The aim of this study is to enroll 185 patients in the intervention group and 185 patients in the control group. Patients in the intervention group come from the same region (Münsterland), the control group will consist of patients outside this region. The patients in the intervention group undergo therapies planned and coordinated through the online platform for 12 months. The patients in the intervention group will be evaluated using the PDQ-39, UPDRS, H\&Y as well as Schwab \& England. The patients in the control group will be evaluated using the PDQ-39.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Coordination through the online platform "JamesAKTIV" | Coordination of the treatment through the online platform "JamesAKTIV" that allows neurologists and therapists to select specialised therapies for the predominant symptoms of the patients and communicate easily about problems during the treatment |
Timeline
- Start date
- 2021-11-28
- Primary completion
- 2024-03-01
- Completion
- 2024-10-01
- First posted
- 2022-02-22
- Last updated
- 2023-04-20
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT05251298. Inclusion in this directory is not an endorsement.